Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy
Apply
KITE-753 vs. Axi-Cel
Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step